elsulfavirine fixed-dose combination
Showing 1 - 25 of >10,000
COPD Trial (Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination)
Not yet recruiting
- COPD
- Ipratropium / Levosalbutamol Fixed Dose Combination
- Ipratropium + Levosalbutamol Free Dose Combination
- (no location specified)
Sep 13, 2023
Healthy Volunteer Study Trial (Fixed-Dose Combination (FDC) Tablet)
Not yet recruiting
- Healthy Volunteer Study
- Fixed-Dose Combination (FDC) Tablet
- (no location specified)
Sep 22, 2023
COPD Trial (Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination)
Not yet recruiting
- COPD
- Ipratropium / Levosalbutamol Fixed Dose Combination
- Ipratropium + Levosalbutamol Free Dose Combination
- (no location specified)
Jun 5, 2023
Postoperative Pain Trial in Seoul (Acetaminophen/Ibuprofen fixed-dose combination)
Not yet recruiting
- Postoperative Pain
- Acetaminophen/Ibuprofen fixed-dose combination
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 5, 2023
Postoperative Pain Trial (acetaminophen/ibuprofen fixed-dose combination, Saline)
Recruiting
- Postoperative Pain
- acetaminophen/ibuprofen fixed-dose combination
- Saline
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 27, 2022
Orthodontic Pain Trial in Salt Lake City (Acetaminophen/Naproxen Sodium Fixed Combination)
Not yet recruiting
- Orthodontic Pain
- Acetaminophen/Naproxen Sodium Fixed Combination
-
Salt Lake City, UtahJBR Clinical Research LLP
Apr 25, 2023
Manganese Safety in Adults Trial (Tralement, Fixed-dose trace element combination product of zinc, copper, and selenious acid)
Not yet recruiting
- Manganese Safety in Adults
- Tralement
- Fixed-dose trace element combination product of zinc, copper, and selenious acid
- (no location specified)
Feb 1, 2023
Manganese Safety in Pediatric Patients Trial (Tralement, Fixed-dose trace element combination product of zinc, copper, and
Not yet recruiting
- Manganese Safety in Pediatric Patients
- Tralement
- Fixed-dose trace element combination product of zinc, copper, and selenious acid
- (no location specified)
Feb 1, 2023
Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)
Not yet recruiting
- Dyslipidemias
- +4 more
- Combination Therapy
- +5 more
- (no location specified)
Aug 22, 2023
Efficacy of Fixed Dose Combination Therapy With Atorvastatin and
Enrolling by invitation
- Primary Hypercholesterolemia
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Nov 4, 2022
Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe
Not yet recruiting
- Primary Hypercholesterolemia
- Mixed Dyslipidemia
- Bempedoic acid and/or its fixed dose combination with ezetimibe
- (no location specified)
Mar 23, 2023
FDC, Diabetes, Type 2 Trial in Cheongju-si (DWC202213, DWJ1563, DWP16001)
Recruiting
- FDC
- Diabetes Mellitus, Type 2
- DWC202213
- +2 more
-
Cheongju-si, Seowon-gu, Korea, Republic ofChungbuk National University Hospital
Feb 10, 2023
Healthy Male Subjects Trial in Auckland, Christchurch (Fixed-Dose Combination of Pertuzumab and Trastuzumab SC (PH FDC SC),
Recruiting
- Healthy Male Subjects
- Fixed-Dose Combination of Pertuzumab and Trastuzumab SC (PH FDC SC)
- +2 more
-
Adelaide, South Australia, Australia
- +3 more
Feb 1, 2023
Pain Trial in Salt Lake City (Acetaminophen/Naproxen Sodium Fixed Combination, Naproxen Sodium, Acetaminophen)
Not yet recruiting
- Pain
- Acetaminophen/Naproxen Sodium Fixed Combination
- +3 more
-
Salt Lake City, UtahJBR Clinical Research LLC
Feb 27, 2023
PD-L1-selected Solid Tumors Trial in Spokane (Tiragolumab and Atezolizumab IV FDC)
Recruiting
- PD-L1-selected Solid Tumors
- Tiragolumab and Atezolizumab IV FDC
-
Spokane, WashingtonMedical Oncology Associates
Jan 13, 2023
Healthy Trial in Merksem (FDC of macitentan/tadalafil (10 mg/20 mg), Macitentan 10 mg, Tadalafil 20 mg)
Completed
- Healthy
- FDC of macitentan/tadalafil (10 mg/20 mg)
- +2 more
-
Merksem, BelgiumClinical Pharmacology Unit
Sep 13, 2022
Type 2 Diabetes Trial in India (dapagliflozin and saxagliptin)
Active, not recruiting
- Type 2 Diabetes Mellitus
- dapagliflozin and saxagliptin
-
Bangalore, India
- +8 more
Jan 17, 2023
Seasonal Allergic Rhinitis Trial in Toronto (Mometasone + Azelastine, Mometasone Furoate, Azelastine Hydrochloride)
Not yet recruiting
- Seasonal Allergic Rhinitis
- Mometasone + Azelastine
- +2 more
-
Toronto, Ontario, CanadaSandoz Investigational Site
May 24, 2023
Type2diabetes, Insulin Resistance Trial (Metformin, Dapagliflozin, Fixed-dose combination of metformin and pioglitazone (500mg
Not yet recruiting
- Type2diabetes
- Insulin Resistance
- Metformin
- +2 more
- (no location specified)
Oct 20, 2022
Type 2 Diabetes Trial in Seoul (Irbesartan/atorvastatin fixed dose combination, Irbesartan SR47436, Atorvastatin)
Completed
- Type 2 Diabetes Mellitus
- Irbesartan/atorvastatin fixed dose combination
- +2 more
-
Seoul, Korea, Republic ofKorea
Apr 5, 2022
Healthy Trial in Edegem (DRV/COBI FDC, COBI, DRV)
Completed
- Healthy
- DRV/COBI FDC
- +2 more
-
Edegem, BelgiumSGS Belgium NV
Oct 25, 2022